Interferon Beta-1B Injection Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 250 mcg

Reference Brands: Betaseron, Extavia(US)

Category: Multiple sclerosis

Interferon Beta-1b modulates the immune system by reducing pro-inflammatory cytokines and inhibiting immune cell activation. It decreases relapse rates, slows disease progression, and reduces lesion formation in multiple sclerosis. Benefits include improved mobility, symptom management, fewer relapses, and enhanced quality of life for MS patients Interferon Beta-1b injection is available in Injectable Solution and strengths such as 250 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Interferon Beta-1b injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Interferon Beta-1b injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Interferon Beta-1b, marketed as Betaseron and Extavia, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis treatment. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trials and manufacturing standards, while the EMA ensures compliance with regional safety and quality requirements.